These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Different aspects of 5 alpha-reductase deficiency in male pseudohermaphroditism and hypothyroidism. Mauvais-Jarvis P; Kuttenn F; Mowszowicz I; Wright F Clin Endocrinol (Oxf); 1981 May; 14(5):459-69. PubMed ID: 7307277 [No Abstract] [Full Text] [Related]
4. Prepubertal diagnosis of steroid 5 alpha-reductase deficiency. Saenger P; Goldman AS; Levine LS; Korth-Schutz S; Muecke EC; Katsumata M; Doberne Y; New MI J Clin Endocrinol Metab; 1978 Apr; 46(4):627-34. PubMed ID: 755047 [TBL] [Abstract][Full Text] [Related]
5. Human minimal androgen insensitivity with normal dihydrotestosterone-binding capacity in cultured genital skin fibroblasts: evidence for an androgen-selective qualitative abnormality of the receptor. Pinsky L; Kaufman M; Killinger DW; Burko B; Shatz D; Volpé R Am J Hum Genet; 1984 Sep; 36(5):965-78. PubMed ID: 6333813 [TBL] [Abstract][Full Text] [Related]
6. Male pseudohermaphroditism: a comparative study of one patient with 5 alpha-reductase deficiency and three patients with the complete form of testicular feminization. Kuttenn F; Mowszowicz I; Wright F; Baudot N; Jaffiol C; Robin M; Mauvais-Jarvis P J Clin Endocrinol Metab; 1979 Dec; 49(6):861-5. PubMed ID: 511977 [No Abstract] [Full Text] [Related]
7. Male pseudohermaphroditism secondary to 5 alpha-reductase deficiency--a model for the role of androgens in both the development of the male phenotype and the evolution of a male gender identity. Imperato-McGinley J; Peterson RE; Gautier T; Sturla E J Steroid Biochem; 1979 Jul; 11(1B):637-45. PubMed ID: 491628 [No Abstract] [Full Text] [Related]
8. Clinical, biochemical and morphologic diagnostic markers in an infant male pseudohermaphrodite patient with compound heterozygous mutations (G115D/R246W) in SRD5A2 gene. Fernández-Cancio M; Rodó J; Andaluz P; Martínez de Osaba MJ; Rodríguez-Hierro F; Esteban C; Carrascosa A; Audí L Horm Res; 2004; 62(5):259-64. PubMed ID: 15528927 [TBL] [Abstract][Full Text] [Related]
9. Role of testosterone binding to the androgen receptor in male sexual differentiation of patients with 5 alpha-reductase deficiency. Maes M; Sultan C; Zerhouni N; Rothwell SW; Migeon CJ J Steroid Biochem; 1979 Oct; 11(4):1385-92. PubMed ID: 513759 [No Abstract] [Full Text] [Related]
10. High dose androgen therapy in male pseudohermaphroditism due to 5 alpha-reductase deficiency and disorders of the androgen receptor. Price P; Wass JA; Griffin JE; Leshin M; Savage MO; Large DM; Bu'Lock DE; Anderson DC; Wilson JD; Besser GM J Clin Invest; 1984 Oct; 74(4):1496-508. PubMed ID: 6480833 [TBL] [Abstract][Full Text] [Related]
11. Familial male pseudohermaphroditism due to deficiency of 5 alpha-reductase. Savage MO; Preece MA; Jeffcoate SL; Ransley PG; Rumsby G; Mansfield MD; Williams DI Clin Endocrinol (Oxf); 1980 Apr; 12(4):397-406. PubMed ID: 7379320 [TBL] [Abstract][Full Text] [Related]
12. Possible mechanisms of androgen resistance in 5 alpha-reductase deficiency: implications for the physiological roles of 5 alpha-reductases. Hodgins MB J Steroid Biochem; 1983 Jul; 19(1B):555-9. PubMed ID: 6887883 [TBL] [Abstract][Full Text] [Related]
13. Hormonal evaluation of a large kindred with complete androgen insensitivity: evidence for secondary 5 alpha-reductase deficiency. Imperato-McGinley J; Peterson RE; Gautier T; Cooper G; Danner R; Arthur A; Morris PL; Sweeney WJ; Shackleton C J Clin Endocrinol Metab; 1982 May; 54(5):931-41. PubMed ID: 6801078 [No Abstract] [Full Text] [Related]
14. [17 alpha-hydroxylase deficiency and 5 alpha-reductase deficiency]. Yoshida H; Shimizu N Nihon Rinsho; 1979 Jun; 37(6):1253-9. PubMed ID: 384051 [No Abstract] [Full Text] [Related]
15. The prevalence of 5 alpha-reductase deficiency in children with ambiguous genitalia in the Dominican Republic. Imperato-McGinley J; Gautier T; Peterson RE; Shackleton C J Urol; 1986 Oct; 136(4):867-73. PubMed ID: 3489839 [TBL] [Abstract][Full Text] [Related]
16. Evidence for secondary 5 alpha-reductase deficiency in genital and supra-pubic skin of subjects with androgen insensitivity syndrome. Wilson SC; Oakey RE; Scott JS Acta Endocrinol (Copenh); 1988 Mar; 117(3):353-60. PubMed ID: 3164158 [TBL] [Abstract][Full Text] [Related]
18. Binding of androgens in 5 alpha-reductase-deficient human genital skin fibroblasts: inhibition by progesterone and its metabolites. Hodgins MB J Endocrinol; 1982 Sep; 94(3):415-27. PubMed ID: 7119651 [TBL] [Abstract][Full Text] [Related]
19. Kinetic evidence for a unique testosterone-receptor complex in 5 alpha-reductase sufficient genital skin fibroblasts and the effects of 5 alpha-reductase deficiency on its formation. Kaufman M; Pinsky L; Trifiro M; Lumbroso R; Sabbaghian N; Gottlieb B J Steroid Biochem Mol Biol; 1993 Jun; 45(6):467-76. PubMed ID: 8518203 [TBL] [Abstract][Full Text] [Related]
20. Clinical, endocrinological, and enzymatic characterization of two patients with 5 alpha-reductase deficiency: evidence that a single enzyme is responsible for the 5 alpha-reduction of cortisol and testosterone. Fisher LK; Kogut MD; Moore RJ; Goebelsmann U; Weitzman JJ; Isaacs H; Griffin JE; Wilson JD J Clin Endocrinol Metab; 1978 Sep; 47(3):653-64. PubMed ID: 263318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]